Charles Wilkinson, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 |
Daniel Craig, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 303-724-2305 |
Michael Handler, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 |
Domenico Gattozzi, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 |
Dr. Timothy Ung, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1635 Aurora Ct, Aurora, CO 80045 Phone: 720-848-0000 |
Steven Ojemann, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 |
Dr. Wayne Matthew Gluf, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 |
Yasuaki Harasaki, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 303-724-2305 |
Dr. Allyson Laura Alexander, MD PHD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 |
John Coon, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 12635 E 17th Ave, Aurora, CO 80045 Phone: 303-724-2305 |
Dr. Othman Alhammad, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 12631 E 17th Ave Ste C307, Aurora, CO 80045 Phone: 720-777-2763 |
Robert Breeze, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 Fax: 303-724-2300 |
Dr. A Samy Youssef, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 |
David Edward Case, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 |
Dr. David Isaac Satzer, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 773-702-2123 Fax: 773-702-3518 |
Dr. David Ryan Ormond, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 12631 E 17th Ave, Academic Office 1, Room 5001, Mailstop C307, Aurora, CO 80045 Phone: 303-724-2284 Fax: 303-724-2300 |
Zach Andrew Folzenlogen, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 |
Dr. Colin C. Buchanan, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1400 S Potomac St, Suite 100, Aurora, CO 80012 Phone: 130-378-3884 |
Hemn Hasan Abdulrahim, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-2763 |
Dr. Angela Downes, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 |
News Archive
YM BioSciences Inc., today announced that two posters have been accepted for presentation at the American Association for Cancer Research (AACR) Annual Meeting to be held from April 17-21 in Washington, DC. The first poster describes the results of the previously reported collaboration with researchers at the University of Toronto for the development of highly potent antibody-radionuclide conjugates for use in the treatment of cancer. The poster will describe activity of 111In-NLS-nimotuzumab against breast cancer cells with high and low EGFR expression.
Schizophrenia, a chronic and debilitating disorder marked in part by auditory hallucinations and paranoia, can strike in late adolescence or early adulthood at a time when people are ready to stand on their own two feet as fully independent adults.
A tumor's goal is simple: to grow, grow, grow, by making more cancer cells. But that often means growing so fast that the oxygen supply gets scarce, at which point cells within the tumor start to suffocate.
Oncolytics Biotech Inc. today announced that it has received a letter of approval from the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to conduct its Phase 3 trial examining REOLYSIN in combination with paclitaxel and carboplatin in patients with platinum-refractory head and neck cancers. This is the same trial that the Company previously reached an agreement on with the U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process.
A recent finding by researchers at the BC Cancer Research Institute and the University of British Columbia may offer a new treatment possibility for people diagnosed with a rare and aggressive form of ovarian cancer.
› Verified 3 days ago